Thalidomide relieves disabling cough for people with deadly lung disease, study shows
In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that ...
Diseases, Conditions, Syndromes
Sep 17, 2012 |
not rated yet |
0
|
Even with personalized assessments, many underestimate disease risks
People with a family history of certain diseases, including heart disease and diabetes, often underestimate their risk for developing them, even after completing a risk assessment and receiving personalized prevention messages, ...
Health
Sep 12, 2012 |
not rated yet |
0
Adding ketamine to opioids doesn't reduce cancer pain
(HealthDay)—Using subcutaneously administered ketamine in a dose-escalating regimen as an adjunct to opioids and standard co-analgesics does not have any clinical benefit in relieving cancer pain, but it ...
Cancer
Sep 11, 2012 |
not rated yet |
0
Advocacy toolkit launched to halt the 'runaway train' of cancer in Africa
Cancer kills more than seven million people a year throughout the world. This is more than HIV/AIDS, tuberculosis and malaria combined, and African countries, which carry a large part of the burden, are the least able of ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Too few girls get HPV vaccine against cancer: CDC
(HealthDay)—Parents and doctors can do more to protect girls from cancers caused by the human papillomavirus (HPV), say U.S. health officials who are concerned by lagging HPV vaccination rates among females. ...
Cancer
Aug 30, 2012 |
1 / 5 (1) |
2
Lung cancer risk unaffected by metformin use in diabetes
(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.
Diabetes
Aug 30, 2012 |
5 / 5 (1) |
0
Cetuximab, paclitaxel combo active in urothelial cancer
(HealthDay)—The monoclonal antibody against epidermal growth factor receptor (EGFR), cetuximab, augments the antitumor activity of paclitaxel in patients with previously treated urothelial cancer, according ...
Cancer
Aug 29, 2012 |
not rated yet |
0
Alcohol by-product destroys blood stem cells
(Medical Xpress)—Scientists at the Medical Research Council (MRC) Laboratory of Molecular Biology have found that stem cells in the body's 'blood cell factory'—the bone marrow—are extremely sensitive to the main breakdown ...
Medical research
Aug 27, 2012 |
4.8 / 5 (5) |
0
|
Post-polyp detection, CRC risk ID'd by colonoscopy factors
(HealthDay) -- In the community setting, after colonoscopic polyp detection, colonoscopy-related factors such as incomplete polyp removal and lack of surveillance colonoscopies are more important than polyp ...
Cancer
Aug 21, 2012 |
not rated yet |
0
New tool for clinicians proves effective predictor of lung cancer risk
A lung cancer risk prediction model developed by scientists at the University of Liverpool has been shown to be a viable tool for selecting high risk individuals for prevention and control programmes.
Cancer
Aug 20, 2012 |
not rated yet |
0
New CDC recommendations on hepatitis C screening
Without other risk factors, all Americans born between 1945 and 1965 should have a one-time screening for the hepatitis C virus (HCV) according to new recommendations being published early online today in Annals of Internal Me ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
Two-thirds of U.S. youth have had oral sex, CDC reports
(HealthDay) -- Two-thirds of Americans aged 15 to 24 have engaged in oral sex, according to a broad new survey of young people's sexual habits.
Health
Aug 16, 2012 |
5 / 5 (1) |
6
Plant-based compound slows breast cancer in a mouse model
The natural plant compound phenethyl isothiocyanate (PEITC) hinders the development of mammary tumors in a mouse model with similarities to human breast cancer progression, according to a study published August 2 in the Journal of ...
Cancer
Aug 02, 2012 |
not rated yet |
0
'Flightless' molecule may prevent cancer from spreading from one tissue to another
Thanks to the "flightless" molecule, the spread of cancer from one tissue to another may one day be grounded. In a new report published in the August 2012 print issue of The FASEB Journal, laboratory experiments show that " ...
Cancer
Jul 31, 2012 |
not rated yet |
0
|
Treating chronic hepatitis C with milk thistle extract does not appear beneficial
Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with treatment-resistant chronic ...
Diseases, Conditions, Syndromes
Jul 17, 2012 |
not rated yet |
0
